Literature DB >> 2113211

Iron overload in haemodialysis patients increases the risk of bacteraemia: a prospective study.

J R Boelaert1, R F Daneels, M L Schurgers, E G Matthys, B Z Gordts, H W Van Landuyt.   

Abstract

The incidence of bacteraemia in relation to the degree of transfusional iron overload was studied prospectively in patients from one haemodialysis unit over a 2-year period, with a total follow-up of 181.3 patient-years in 158 patients. Every 3 months, the patients were classified according to the serum ferritin in one of three groups: less than 500, 500-1000 or greater than 1000 micrograms/l. Twenty-nine episodes of bacteraemia were recorded over 181.3 patient-years (yearly incidence of 0.160). The yearly incidence of bacteraemia was 0.1173 and 0.1101 for ferritin less than 500 and 500-1000 micrograms/l (no significant difference), with a cumulative incidence for both groups of 0.1164. In the ferritin greater than 1000 micrograms/l group, the incidence was 0.3404 (P less than or equal to 0.005 versus the ferritin less than or equal to 1000 micrograms/l group). After stratification for patient's age (at inclusion in the study) and duration of haemodialysis therapy, the higher incidence of bacteraemia in the ferritin greater than 1000 versus less than or equal to 1000 micrograms/l groups persisted (P less than or equal to 0.005). This prospective study confirms previous retrospective studies in showing that acquired transfusional iron overload in haemodialysis is associated with a greater risk of bacteraemia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2113211     DOI: 10.1093/ndt/5.2.130

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  16 in total

1.  Iron sucrose impairs phagocytic function and promotes apoptosis in polymorphonuclear leukocytes.

Authors:  Hirohito Ichii; Yuichi Masuda; Tania Hassanzadeh; Mateen Saffarian; Sastry Gollapudi; Nosratola D Vaziri
Journal:  Am J Nephrol       Date:  2012-06-19       Impact factor: 3.754

2.  Safety of Intravenous Iron in Dialysis: A Systematic Review and Meta-Analysis.

Authors:  Ingrid Hougen; David Collister; Mathieu Bourrier; Thomas Ferguson; Laura Hochheim; Paul Komenda; Claudio Rigatto; Navdeep Tangri
Journal:  Clin J Am Soc Nephrol       Date:  2018-02-20       Impact factor: 8.237

Review 3.  Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.

Authors:  Steven Y C Tong; Joshua S Davis; Emily Eichenberger; Thomas L Holland; Vance G Fowler
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

Review 4.  Iron and infection in hemodialysis patients.

Authors:  Julie H Ishida; Kirsten L Johansen
Journal:  Semin Dial       Date:  2013-12-12       Impact factor: 3.455

5.  Intravenous iron exposure and mortality in patients on hemodialysis.

Authors:  Dana C Miskulin; Navdeep Tangri; Karen Bandeen-Roche; Jing Zhou; Aidan McDermott; Klemens B Meyer; Patti L Ephraim; Wieneke M Michels; Bernard G Jaar; Deidra C Crews; Julia J Scialla; Stephen M Sozio; Tariq Shafi; Albert W Wu; Courtney Cook; L Ebony Boulware
Journal:  Clin J Am Soc Nephrol       Date:  2014-10-15       Impact factor: 8.237

6.  Iron in granulocytes of nephrotic patients determined by Zeeman electrothermal atomic absorption spectrophotometry.

Authors:  M Matthys; V Blaton; J Spincemaille
Journal:  Biol Trace Elem Res       Date:  1992 Jan-Mar       Impact factor: 3.738

7.  The effect of recombinant human erythropoietin treatment on insulin resistance and inflammatory markers in non-diabetic patients on maintenance hemodialysis.

Authors:  Z Rasic-Milutinovic; G Perunicic-Pekovic; A Cavala; Z Gluvic; L Bokan; S Stankovic
Journal:  Hippokratia       Date:  2008-07       Impact factor: 0.471

Review 8.  Iron dosing in kidney disease: inconsistency of evidence and clinical practice.

Authors:  Adam E Gaweda; Yelena Z Ginzburg; Yossi Chait; Michael J Germain; George R Aronoff; Eliezer Rachmilewitz
Journal:  Nephrol Dial Transplant       Date:  2014-05-12       Impact factor: 5.992

9.  Catheter survival and comparison of catheter exchange methods in children on hemodialysis.

Authors:  Ali Mirza Onder; Jayanthi Chandar; Marie Saint-Vil; Gabriela Lopez-Mitnik; Carolyn L Abitbol; Gaston Zilleruelo
Journal:  Pediatr Nephrol       Date:  2007-05-22       Impact factor: 3.714

10.  Endotoxin binding by sevelamer: potential impact on nutritional status.

Authors:  Natsuki Kubotera; Alexander J Prokopienko; Adinoyi O Garba; Amy Barton Pai
Journal:  Int J Nephrol       Date:  2013-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.